Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conservation of Natural Resources | 5 | 2023 | 211 | 2.160 |
Why?
|
| Population Density | 3 | 2023 | 193 | 1.410 |
Why?
|
| Biodiversity | 3 | 2023 | 347 | 1.210 |
Why?
|
| Language | 3 | 2019 | 1543 | 0.850 |
Why?
|
| Chest Pain | 3 | 2019 | 1091 | 0.820 |
Why?
|
| Culture | 3 | 2018 | 623 | 0.810 |
Why?
|
| Social Change | 1 | 2020 | 153 | 0.670 |
Why?
|
| Forestry | 1 | 2018 | 9 | 0.640 |
Why?
|
| Liver Transplantation | 2 | 2021 | 2330 | 0.630 |
Why?
|
| Agriculture | 1 | 2018 | 190 | 0.550 |
Why?
|
| Geography | 2 | 2019 | 656 | 0.540 |
Why?
|
| Social Control, Formal | 1 | 2016 | 108 | 0.530 |
Why?
|
| Hospital Units | 1 | 2017 | 142 | 0.520 |
Why?
|
| Models, Psychological | 1 | 2020 | 829 | 0.520 |
Why?
|
| Critical Pathways | 1 | 2019 | 474 | 0.510 |
Why?
|
| Observation | 1 | 2017 | 310 | 0.490 |
Why?
|
| Specialization | 1 | 2019 | 778 | 0.460 |
Why?
|
| Early Diagnosis | 1 | 2019 | 1186 | 0.450 |
Why?
|
| Behavior | 1 | 2016 | 541 | 0.440 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2012 | 123 | 0.440 |
Why?
|
| Ecosystem | 2 | 2018 | 490 | 0.430 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 1436 | 0.420 |
Why?
|
| Hospitalization | 5 | 2023 | 10721 | 0.410 |
Why?
|
| Cultural Diversity | 1 | 2016 | 369 | 0.410 |
Why?
|
| Social Values | 1 | 2013 | 225 | 0.400 |
Why?
|
| Social Behavior | 1 | 2018 | 1135 | 0.390 |
Why?
|
| Outpatients | 1 | 2019 | 1597 | 0.380 |
Why?
|
| Social Class | 1 | 2020 | 2004 | 0.370 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 15502 | 0.340 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 215 | 0.340 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 2113 | 0.310 |
Why?
|
| Motivation | 1 | 2018 | 2006 | 0.310 |
Why?
|
| Cardiology | 1 | 2019 | 1656 | 0.310 |
Why?
|
| Models, Theoretical | 2 | 2019 | 3575 | 0.300 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 4235 | 0.300 |
Why?
|
| Coronary Artery Disease | 3 | 2021 | 6403 | 0.290 |
Why?
|
| Dyspnea | 2 | 2012 | 1347 | 0.280 |
Why?
|
| Health Services Accessibility | 2 | 2019 | 5440 | 0.230 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 1555 | 0.200 |
Why?
|
| Databases, Factual | 1 | 2016 | 7968 | 0.180 |
Why?
|
| Mexico | 1 | 2023 | 764 | 0.180 |
Why?
|
| Diagnosis, Differential | 6 | 2019 | 12973 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 4243 | 0.170 |
Why?
|
| Heart Failure | 5 | 2023 | 11671 | 0.160 |
Why?
|
| History, Ancient | 1 | 2018 | 212 | 0.150 |
Why?
|
| Humans | 30 | 2023 | 761596 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 1 | 2020 | 999 | 0.140 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2021 | 323 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 7879 | 0.140 |
Why?
|
| Poisson Distribution | 1 | 2018 | 504 | 0.140 |
Why?
|
| Glucosides | 1 | 2021 | 512 | 0.140 |
Why?
|
| Lung | 2 | 2012 | 10002 | 0.130 |
Why?
|
| Hypovolemia | 1 | 2016 | 48 | 0.130 |
Why?
|
| Recreation | 1 | 2016 | 125 | 0.130 |
Why?
|
| Munchausen Syndrome | 1 | 2015 | 19 | 0.130 |
Why?
|
| North America | 1 | 2019 | 1276 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 794 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2018 | 992 | 0.120 |
Why?
|
| Malingering | 1 | 2015 | 75 | 0.120 |
Why?
|
| Coronary Angiography | 3 | 2021 | 4471 | 0.120 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 916 | 0.120 |
Why?
|
| Ecology | 1 | 2014 | 104 | 0.120 |
Why?
|
| Vanuatu | 1 | 2013 | 5 | 0.110 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 261 | 0.110 |
Why?
|
| Shock | 1 | 2016 | 314 | 0.110 |
Why?
|
| Fishes | 1 | 2016 | 603 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1258 | 0.110 |
Why?
|
| Probability | 1 | 2018 | 2477 | 0.110 |
Why?
|
| Cardiovascular Agents | 1 | 2019 | 840 | 0.110 |
Why?
|
| Patient Readmission | 2 | 2019 | 3271 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 1112 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 3415 | 0.100 |
Why?
|
| Population Groups | 1 | 2013 | 208 | 0.100 |
Why?
|
| Fasciitis | 1 | 2013 | 67 | 0.100 |
Why?
|
| Environment | 1 | 2018 | 1123 | 0.100 |
Why?
|
| Knowledge | 1 | 2013 | 177 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 1 | 2016 | 436 | 0.100 |
Why?
|
| Catheterization | 1 | 2017 | 1428 | 0.100 |
Why?
|
| Religion | 1 | 2014 | 372 | 0.090 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2013 | 123 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15936 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2023 | 7828 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2012 | 13381 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2019 | 2188 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1835 | 0.090 |
Why?
|
| Social Environment | 1 | 2015 | 1020 | 0.080 |
Why?
|
| Male | 11 | 2020 | 360846 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2021 | 80647 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6345 | 0.080 |
Why?
|
| Female | 10 | 2020 | 392705 | 0.080 |
Why?
|
| Middle Aged | 7 | 2020 | 220921 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15266 | 0.080 |
Why?
|
| Myocardial Infarction | 2 | 2019 | 11461 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2019 | 2775 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2012 | 1085 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2021 | 5496 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 23996 | 0.070 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2016 | 1400 | 0.070 |
Why?
|
| Aged | 6 | 2023 | 169310 | 0.070 |
Why?
|
| Homozygote | 1 | 2011 | 1776 | 0.060 |
Why?
|
| Medicare | 1 | 2023 | 6770 | 0.060 |
Why?
|
| Echocardiography | 3 | 2013 | 4989 | 0.060 |
Why?
|
| Euplotes | 1 | 2004 | 4 | 0.060 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2004 | 15 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20100 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9327 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 1407 | 0.060 |
Why?
|
| Diuresis | 1 | 2023 | 106 | 0.050 |
Why?
|
| Risk Factors | 3 | 2019 | 74213 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 59260 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 5127 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7391 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 41495 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8656 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 1578 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2021 | 20568 | 0.040 |
Why?
|
| Diuretics | 1 | 2023 | 610 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2014 | 5079 | 0.040 |
Why?
|
| Telomerase | 1 | 2004 | 745 | 0.040 |
Why?
|
| Heart | 1 | 2012 | 4404 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2001 | 672 | 0.040 |
Why?
|
| Markov Chains | 1 | 2021 | 966 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 221210 | 0.030 |
Why?
|
| Phylogeny | 1 | 2004 | 2811 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1886 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 352 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2932 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2011 | 22176 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1841 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 88326 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2001 | 2856 | 0.020 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2015 | 549 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58984 | 0.020 |
Why?
|
| Periodontitis | 1 | 2016 | 568 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2986 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3443 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3449 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 1086 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 5493 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 21019 | 0.020 |
Why?
|
| Animals | 3 | 2016 | 168475 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 698 | 0.020 |
Why?
|
| Liver | 1 | 2021 | 7528 | 0.020 |
Why?
|
| Gene Components | 1 | 2004 | 27 | 0.010 |
Why?
|
| Fatigue | 1 | 2011 | 1552 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2004 | 196 | 0.010 |
Why?
|
| Mastectomy | 1 | 2011 | 1822 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2011 | 1927 | 0.010 |
Why?
|
| Cyclin A | 1 | 2001 | 60 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 12130 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
| Cyclin E | 1 | 2001 | 156 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 582 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 269 | 0.010 |
Why?
|
| Histone Deacetylase 1 | 1 | 2001 | 133 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2001 | 169 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 213 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2180 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8527 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 3615 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2013 | 6377 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2011 | 3807 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 1434 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 2567 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2001 | 1646 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15843 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1529 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 910 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2707 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2001 | 720 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 9610 | 0.010 |
Why?
|
| United States | 1 | 2023 | 72340 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2645 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6131 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9280 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 4740 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 12441 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3733 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39106 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 2910 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2448 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13446 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 12149 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 17635 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5790 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 54423 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7593 | 0.000 |
Why?
|
Concepts
(189)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_